Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5507-5514

  Bennett, Jami L ^a   Blanchet, Marie Renée ^a   Zhao, Linlin ^b   Zbytnuik, Lori ^a,b   Antignano, Frann ^a   Gold, Matthew ^a   Kubes, Paul ^b   McNagny, Kelly M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CD34 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CD34 GENE; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE MUTATION; INFLAMMATION; MACROPHAGE; MAST CELL; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL MOTION; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; TRANSPLANTATION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; SPINAL CORD;

EID: 66949128718     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801485     Document Type: Article

References (34)

1. Metcalfe, D. D., D. Baram, and Y. A. Mekori. 1997. Mast cells. Physiol. Rev. 77: 1033-1079.
2. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
3. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
4. Blanchet, M. R., S. Maltby, D. J. Haddon, H. Merkens, L. Zbytnuik, and K. M. McNagny. 2007. CD34 facilitates the development of allergic asthma. Blood 110: 2005-2012.
5. Rijnierse, A., A. S. Koster, F. P. Nijkamp, and A. D. Kraneveld. 2006. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J. Immunol. 176: 4375-4384. (Pubitemid 44264418)
6. Yamamoto, T., Y. Takahashi, S. Takagawa, I. Katayama, and K. Nishioka. 1999. Animal model of sclerotic skin, II: bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/Wv mice. J. Rheumatol. 26: 2628-2634.
7. Heissig, B., S. Rafii, H. Akiyama, Y. Ohki, Y. Sato, T. Rafael, Z. Zhu, D. J. Hicklin, K. Okumura, H. Ogawa, et al. 2005. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 202: 739-750. (Pubitemid 41345963)
8. Coussens, L. M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb, G. H. Caughey, and D. Hanahan. 1999. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13: 1382-1397.
9. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4: 1199-1205.
10. Metz, M., A. M. Piliponsky, C. C. Chen, V. Lammel, M. Abrink, G. Pejler, M. Tsai, and S. J. Galli. 2006. Mast cells can enhance resistance to snake and honeybee venoms. Science 313: 526-530. (Pubitemid 44148458)
11. Kitamura, Y., S. Go, and K. Hatanaka. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452. (Pubitemid 8395558)
12. Grimbaldeston, M. A., C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
13. Drew, E., H. Merkens, S. Chelliah, R. Doyonnas, and K. M. McNagny. 2002. CD34 is a specific marker of mature murine mast cells. Exp. Hematol. 30: 1211-1218.
14. Gounaris, E., S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, et al. 2007. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. USA 104: 19977-19982.
15. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302. (Pubitemid 26160700)
16. Steinman, L., and S. S. Zamvil. 2006. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60: 12-21.
17. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
18. Robbie-Ryan, M., M. B. Tanzola, V. H. Secor, and M. A. Brown. 2003. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170: 1630-1634. (Pubitemid 36197375)
19. Tanzola, M. B., M. Robbie-Ryan, C. A. Gutekunst, and M. A. Brown. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171: 4385-4391.
20. Sayed, B. A., and M. A. Brown. 2007. Mast cells as modulators of T-cell responses. Immunol. Rev. 217: 53-64. (Pubitemid 46718157)
21. Drew, E., J. S. Merzaban, W. Seo, H. J. Ziltener, and K. M. McNagny. 2005. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 22: 43-57. (Pubitemid 40143450)
22. Suzuki, A., D. P. Andrew, J. A. Gonzalo, M. Fukumoto, J. Spellberg, M. Hashiyama, H. Takimoto, N. Gerwin, I. Webb, G. Molineux, et al. 1996. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood 87: 3550-3562. (Pubitemid 26129581)
23. Fife, B. T., G. B. Huffnagle, W. A. Kuziel, and W. J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 899-905.
24. Nielsen, J. S., and K. M. McNagny. 2007. Influence of host irradiation on longterm engraftment by CD34-deficient hematopoietic stem cells. Blood 110: 1076-1077.
25. Krause, D. S., T. Ito, M. J. Fackler, O. M. Smith, M. I. Collector, S. J. Sharkis, and W. S. May. 1994. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84: 691-701. (Pubitemid 24223862)
26. Ladeby, R., M. Wirenfeldt, I. Dalmau, R. Gregersen, D. Garcia-Ovejero, A. Babcock, T. Owens, and B. Finsen. 2005. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50: 121-131. (Pubitemid 40695266)
27. Radinger, M., A. K. Johansson, B. Sitkauskiene, M. Sjostrand, and J. Lotvall. 2004. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J. Allergy Clin. Immunol. 113: 1109-1116. (Pubitemid 38857993)
28. Wong, E., E. W. Morgan, and D. M. MacDonald. 1982. The chloroacetate esterase reaction for mast cells in dermatopathology: a comparison with metachromatic staining methods. Acta Derm. Venereol. 62: 431-434. (Pubitemid 12024331)
29. Correale, J., and M. Farez. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol. 61: 97-108. (Pubitemid 46363837)
30. La Flamme, A. C., K. Ruddenklau, and B. T. Backstrom. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71: 4996-5004. (Pubitemid 37070742)
31. Poliak, S., F. Mor, P. Conlon, T. Wong, N. Ling, J. Rivier, W. Vale, and L. Steinman. 1997. Stress and autoimmunity: the neuropeptides corticotropinreleasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158: 5751-5756. (Pubitemid 127483980)
32. Tuomisto, L., H. Kilpaelainen, and P. Riekkinen. 1983. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 13: 255-257.
33. Rozniecki, J. J., S. L. Hauser, M. Stein, R. Lincoln, and T. C. Theoharides. 1995. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37: 63-66.
34. Adams R. A., C. Schachtrup, D. Davalos, I. Tsigelny, and K. Akassoglou. 2007. Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr. Med. Chem. 14: 2925-2936.